BioSpace News Archive

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry 2021 Virtual Meeting.

Results showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment

AMRA Medical (“AMRA”), a global leader in body composition analysis, announced today that Barbara J. Dalton, Ph. D. has been appointed to its Board of Directors

James Lanthier, CEO of Mindset, commented, “N,N-dimethyltryptamine (DMT) & 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) are potent, short-acting psychedelic drugs that produce strong hallucinogenic effects.

The study was recently published in the Scientific Journal titled “Cancers”.

As we continue to roll out COVID-19 vaccines across the country, the Government of Canada is committed to addressing and reducing barriers to vaccination.

ALS patients showed a diminished disease progression based on analysis of functional endpoints. The study was recently published in the journal Brain.

IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS), today announced the release of a series of reports detailing methodology for developing breakthrough COVID-19 testing techniques based on guidelines and funding provided by the U.S. National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx).

Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that its common stock has begun trading on the Nasdaq Global Select Market under the ticker symbol “AVAH.”

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.